374 participants
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-03-15
- Start Date:
- 2024-02-18
- Completion:
- 2025-12-31
Conditions
- Immunotherapy
- Hyperprogression
- Biomarker
No Results Yet